Grown Rogue International (GRUSF) Tax Provisions (2010 - 2026)
Grown Rogue International (GRUSF) posted quarterly Tax Provisions of $516871.0 for Q1 2026, down 18.13% year-over-year from $631310.0 in Q1 2025, and down 100.0% quarter-over-quarter from $578.9 billion in Q4 2025.
Grown Rogue International (GRUSF) Tax Provisions (2010 - 2026) Analysis & Trends
Grown Rogue International's Tax Provisions history runs 7 years deep, the most recent figure standing at $516871.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 18.13% year-over-year to $516871.0; the TTM figure through Mar 2026 stood at $502.1 billion (down 45.6% YoY), while the FY2025 annual figure was $1.6 million, up 163.03% from the prior year.
- Tax Provisions for Q1 2026 stood at $516871.0, down from $578.9 billion in the prior quarter.
- The five-year high for Tax Provisions was $1181.9 billion in Q4 2024, with the low at -$258.9 billion in Q3 2024.
- The 5-year median for Tax Provisions is -$219959.0 (2023), against an average of $95.0 billion.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions sank 101.94% in 2023, then jumped 308152514.44% in 2024.
- Grown Rogue International's Tax Provisions stood at -$37018.0 in 2022, then soared by 1136.09% to $383539.0 in 2023, then surged by 308152514.44% to $1181.9 billion in 2024, then sank by 51.02% to $578.9 billion in 2025, then slumped by 100.0% to $516871.0 in 2026.
- Business Quant data shows GRUSF's Tax Provisions at $516871.0 in Q1 2026, $578.9 billion in Q4 2025, and -$76.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Grown Rogue International | 116.22 Mn | 104.68 Mn | 5.37 Mn | 871,331.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 871,331.00 |
| Mar 31, 2026 | 516,871.00 |
| Dec 31, 2025 | 578.88 Bn |
| Sep 30, 2025 | -76.81 Bn |
| Jun 30, 2025 | -251,077.00 |
| Mar 31, 2025 | 631,310.00 |
| Dec 31, 2024 | 1,181.89 Bn |
| Sep 30, 2024 | -258.88 Bn |
| Jun 30, 2024 | -403,941.26 |
| Mar 31, 2024 | -370,525.00 |
| Dec 31, 2023 | 383,539.00 |
| Oct 31, 2023 | -296,178.00 |
| Jul 31, 2023 | -300,677.00 |
| Apr 30, 2023 | -219,959.00 |
| Jan 31, 2023 | -74,754.00 |
| Jan 31, 2022 | -37,018.00 |
| Apr 30, 2020 | 1,100.00 |
| Jan 31, 2020 | -32.00 |
| Nov 30, 2010 | -34,729.90 |